Vanda Pharmaceuticals Inc.'s oral drug TASIMELTEON has received FDA approval, representing a potential therapeutic option for a previously underserved...
Financial News Archive
SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s
# FDA Approves AstraZeneca's FARXIGA for Diabetes Treatment AstraZeneca Pharmaceuticals LP received FDA approval for FARXIGA (dapagliflozin), an oral...
On January 8, 2014, Archis Pharma LLC received FDA approval for its ANDA 091248, launching oral mycophenolic acid to provide a new therapeutic option ...
Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. received FDA approval for the alternative ANDA 091431 to market Amlodipine and Benazepri...
Sun Pharma received FDA approval for an Abbreviated New Drug Application, a regulatory clearance expected to facilitate generic market entry and drive...
Par Health USA, LLC has secured FDA approval for injection, epinephrine, intended for the management of severe allergic reactions, historically openin...
Mylan Pharmaceuticals Inc. received FDA approval for its generic version of the cardiovascular drug Amlodipine and Atorvastatin, offering a cost-effec...
Fresenius Kabi secured FDA approval for its intramuscular morphine sulfate formulation, significantly expanding its therapeutic options within the com...
Westminster Pharmaceuticals, LLC announced final FDA approval today for its ANDA 203769, aiming to introduce metformin hydrochloride tablets to the ma...
# FDA Approves ANDA for AUROLIFE PHARMA LLC AUROLIFE PHARMA LLC has received FDA approval for ANDA 202580, expanding its generic drug portfolio and p...
American Regent, Inc. has received FDA approval for Injectable Ferric Carboxymaltose (INJECTAFER), a treatment that could alleviate current supply con...
HIKMA Pharmaceuticals announced the FDA approval of its Generic ANDA application, a strategic milestone expected to bolster market share and expand re...
Aurolife Pharma, LLC announced the approval of an abbreviated new drug application ORAL OXYCODONE AND ACETAMINOPHEN, paving the way for its entry into...
**Amneal Pharmaceuticals of New York LLC announced the approval of its Abbreviated New Drug Application (ANDA200828) for the generic oral drug lamotri...
HIKMA announced early FDA approval for its generic version of this pharmaceutical product on July 12, 2013, positioning itself to compete in this spec...
PH HEALTH has secured FDA approval for the pending generic application ANDA090733, a move that positions the company to capture new market share and d...
Actavis Elizabeth’s FDA approval of this ANDA clears the regulatory path for a generic entry, positioning the company to compete aggressively against ...
On July 11, 2013, PH HEALTH received FDA approval for ANDA090734, introducing a new therapeutic option to the market. This clearance is expected to ge...
# FDA Approves Sun Pharmaceutical's Generic Finasteride Sun Pharmaceutical Industries, Inc. received FDA approval for its generic finasteride formula...
Glenmark Pharmaceuticals today announced the FDA approval of its Abbreviated New Drug Application (ANDA091394) for generic riluzole, positioning the c...